TYK2 drugs for Psoriasis
12 tracked TYK2 drugs in the Psoriasis race. The class explanation lives on the TYK2 page; the full indication pipeline across every mechanism is on the Psoriasis page.
1 approved / phase 47 Phase 31 Phase 2/32 Phase 21 Phase 1/2
Head-to-head evidence: AC-201 vs Envudeucitinib · AC-201 vs Fadeucravacitinib · AC-201 vs Lomedeucitinib · AC-201 vs Nomelcitinib (D-2570) · AC-201 vs TQH3906 · AC-201 vs deucravacitinib